| TAEHYUNG, K., Daniela ŽÁČKOVÁ, Ivana JEŽÍŠKOVÁ, Anežka KVETKOVÁ, Tomáš JURČEK, YS. YOO, H. LEE, KH. KIM, MH. CHANG, SY. YI, J. MEDEIROS, S. ABELSON and D. KIM. Somatic mutations in myeloid transcription factors and in activated signaling pathway, but not in epigenetic modifier pathway, predict the risk of tratment failure and progression to advanced phase in chronic myeloid leukemia. In 64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood. 2022. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{2241062,
author = {Taehyung, K. and Žáčková, Daniela and Ježíšková, Ivana and Kvetková, Anežka and Jurček, Tomáš and Yoo, YS. and Lee, H. and Kim, KH. and Chang, MH. and Yi, SY. and Medeiros, J. and Abelson, S. and Kim, D.},
booktitle = {64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood},
title = {Somatic mutations in myeloid transcription factors and in activated signaling pathway, but not in epigenetic modifier pathway, predict the risk of tratment failure and progression to advanced phase in chronic myeloid leukemia},
year = {2022}
}
TY - CONF
ID - 2241062
AU - Taehyung, K. - Žáčková, Daniela - Ježíšková, Ivana - Kvetková, Anežka - Jurček, Tomáš - Yoo, YS. - Lee, H. - Kim, KH. - Chang, MH. - Yi, SY. - Medeiros, J. - Abelson, S. - Kim, D.
PY - 2022
TI - Somatic mutations in myeloid transcription factors and in activated signaling pathway, but not in epigenetic modifier pathway, predict the risk of tratment failure and progression to advanced phase in chronic myeloid leukemia
ER -
TAEHYUNG, K., Daniela ŽÁČKOVÁ, Ivana JEŽÍŠKOVÁ, Anežka KVETKOVÁ, Tomáš JURČEK, YS. YOO, H. LEE, KH. KIM, MH. CHANG, SY. YI, J. MEDEIROS, S. ABELSON and D. KIM. Somatic mutations in myeloid transcription factors and in activated signaling pathway, but not in epigenetic modifier pathway, predict the risk of tratment failure and progression to advanced phase in chronic myeloid leukemia. In \textit{64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood}. 2022.
|
